Bristol-Myers Squibb Company 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
BRISTOL MYERS SQUIBB CO BMY |
5,075,304 4.300% |
0 (Unchanged) |
Filing |
| 2023-12-04 4:13 pm Purchase |
2023-11-27 | 13G | Avidity Biosciences, Inc. RNA |
BRISTOL MYERS SQUIBB CO BMY |
5,075,304 6.400% |
5,075,304 (New Position) |
Filing |